论文部分内容阅读
探讨肿瘤标志物CEA、CK19、SCC检测在肺癌诊断中的临床价值。选择22例肺癌患者为肺癌组,同期30例健康体检者为对照组,检测两者的CEA、CK19、SCC水平并进行分析。肺癌组肿瘤标志物CEA、CK19、SCC水平显著高于正常对照组(P<0.05);肺癌组肿瘤标志物CEA、CK19检测结果的阳性率显著高于正常对照组(P<0.05);肺癌组CEA与血清CK19呈正相关(r=0.510,P<0.05)。ROC曲线显示CEA、CK19、SCC曲线下面积分别为0.686、0.742、0.719,CK19的诊断价值最大。肿瘤标志物CEA、CK19、SCC检测是肺癌患者临床诊断重要的血液指标。
To investigate the clinical value of tumor markers CEA, CK19 and SCC in the diagnosis of lung cancer. Twenty-two patients with lung cancer were selected as the lung cancer group and 30 healthy individuals were selected as the control group. CEA, CK19 and SCC levels were measured and analyzed. The levels of CEA, CK19 and SCC in lung cancer were significantly higher than those in normal control (P <0.05). The positive rates of CEA and CK19 in lung cancer were significantly higher than those in normal control (P <0.05) CEA was positively correlated with serum CK19 (r = 0.510, P <0.05). ROC curve showed CEA, CK19, SCC area under the curve were 0.686,0.742,0.719, CK19 diagnosis of the largest. Tumor markers CEA, CK19, SCC detection is an important blood index for the clinical diagnosis of lung cancer patients.